Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, Luigi Fornaro & Alessia Villani. (2022) Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge. Expert Opinion on Drug Safety 21:10, pages 1249-1257.
Read now
Read now
Lluís Puig. (2020) The safety of ixekizumab in psoriasis drug therapy. Expert Opinion on Drug Safety 19:2, pages 117-130.
Read now
Read now
Christoffer Blegvad, Lone Skov & Claus Zachariae. (2019) Ixekizumab for the treatment of psoriasis: an update on new data since first approval. Expert Review of Clinical Immunology 15:2, pages 111-121.
Read now
Read now
Alessandro Giunta, Alessandra Ventura, Maria Sole Chimenti, Luca Bianchi & Maria Esposito. (2017) Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy. Drug Design, Development and Therapy 11, pages 1643-1651.
Read now
Read now
Articles from other publishers (4)
Dimitri Luz Felipe da Silva, Elisa Nunes Secamilli, Mariana Valbon Beleli, Juliana Yumi Massuda, Andrea F.E.C. Franca & Renata F. Magalhães. (2022) Immunobiologicals in dermatology. Anais Brasileiros de Dermatologia 97:3, pages 275-283.
Crossref
Crossref
Weiwei Guo, Fengying Xu, Zhuochen Zhuang, Zhe Liu, Jiming Xie & Liping Bai. (2021) Ebosin Ameliorates Psoriasis-Like Inflammation of Mice via miR-155 Targeting tnfaip3 on IL-17 Pathway. Frontiers in Immunology 12.
Crossref
Crossref
Nannan Sun, Congmin Yuan, Xiaojun Ma, Yonghui Wang, Xianfeng Gu & Wei Fu. (2018) Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation. Molecules 23:12, pages 3181.
Crossref
Crossref
Jeffrey T. Guptill, Madhu Soni & Matthew N. Meriggioli. (2015) Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis. Neurotherapeutics 13:1, pages 118-131.
Crossref
Crossref